{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fimmunotherapy-for-hcc-z9_qLkwS","width":444,"version":"1.0","type":"rich","title":"Incorporating Immune Checkpoint Inhibitors Across the Disease Spectrum of Hepatocellular Carcinoma","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/b46cc87d-1372-40f7-8d46-e27c0bd207d7/100627-hcc-asco-adjacent-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/4948b2b9-11e5-4e52-8744-c0cbe52a9b10\" height=\"200\" width=\"100%\" title=\"Incorporating Immune Checkpoint Inhibitors Across the Disease Spectrum of Hepatocellular Carcinoma\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to this audio podcast with expert insights and overview of the latest data for immune checkpoint inhibitors for advanced or metastatic hepatocellular carcinoma (HCC), for intermediate HCC in combination with TACE, and the latest guidelines for high-risk early HCC. "}